GHK-Cu vs SS-31: Mechanism, Half-Life & Research Use

While both GHK-Cu and SS-31 are widely evaluated in cell bioenergetics and tissue repair models, their molecular targets and biochemical pathways are fundamentally distinct. GHK-Cu operates primarily as a copper-binding tripeptide modulating extracellular matrix synthesis and gene expression, whereas SS-31 directly targets inner mitochondrial membrane cardiolipin to preserve electron transport chain efficiency.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

While both GHK-Cu and SS-31 are widely evaluated in cell bioenergetics and tissue repair models, their molecular targets and biochemical pathways are fundamentally distinct. GHK-Cu operates primarily as a copper-binding tripeptide modulating extracellular matrix synthesis and gene expression, whereas SS-31 directly targets inner mitochondrial membrane cardiolipin to preserve electron transport chain efficiency.

Reviewed by PX1 Research scientific team

Key takeaways

  • [GHK-Cu](/research-peptides/ghk-cu) (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide complex studied for extracellular matrix remodeling, collagen synthesis, and gene expression regulation.
  • To assist laboratory personnel in protocol design, the primary biochemical parameters, molecular targets, and physical characteristics of [GHK-Cu](/research-peptides/ghk-cu) and [SS-31](/research-peptides/ss-31) are summarized below.
  • [GHK-Cu](/research-peptides/ghk-cu) functions as a high-affinity carrier of copper(II) ions, a critical cofactor for enzymes such as lysyl oxidase (LOX) and superoxide dismutase (SOD1).
  • [SS-31](/research-peptides/ss-31) (D-Arg-2',6'-Dmt-Lys-Phe-NH2) features an alternating aromatic-cationic motif that allows it to penetrate cell membranes and concentrate selectively within the inner mitochondrial membrane.

Direct Comparison: GHK-Cu vs SS-31

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide complex studied for extracellular matrix remodeling, collagen synthesis, and gene expression regulation. In contrast, SS-31 (Elamipretide) is a synthetic tetrapeptide that selectively targets cardiolipin within the inner mitochondrial membrane to mitigate oxidative stress and restore ATP synthesis. While GHK-Cu modulates structural tissue repair and dermal bioenergetics, SS-31 regulates organellar bioenergetics and cellular respiration under metabolic stress.

In preclinical settings, investigators choose between these compounds based on whether their experimental endpoints center on structural protein expression and extracellular matrix dynamics (GHK-Cu) or mitochondrial membrane stability and reactive oxygen species (ROS) attenuation (SS-31).

Biochemical Comparison Criteria: GHK-Cu and SS-31

To assist laboratory personnel in protocol design, the primary biochemical parameters, molecular targets, and physical characteristics of GHK-Cu and SS-31 are summarized below.

| Criteria | GHK-Cu (Copper Tripeptide) | SS-31 (Elamipretide) | | :--- | :--- | :--- | | **Molecular Target** | High-affinity copper binding; extracellular matrix (ECM) transcription factors | Cardiolipin on the inner mitochondrial membrane (IMM) | | **Mechanistic Class** | Matrix remodeling tripeptide complex; copper ion carrier | Mitochondria-targeted antioxidant / bioenergetic stabilizer | | **Reported Plasma Half-Life** | ~0.5–4 hours in rodent plasma models | ~1–2 hours in rodent models; extended tissue retention in mitochondria | | **Solubility Profile** | Highly water-soluble in aqueous buffers (PBS, sterile water) | Highly water-soluble in aqueous solutions and saline buffers | | **Typical Preclinical Model** | Dermal fibroblast cultures, full-thickness excision wound assays, skin aging models | Ischemia-reperfusion assays, isolated mitochondrial assays, neurodegenerative disease models | | **Vial Sizes Available** | Available in standard laboratory units via our all-peptides catalog | Available in standardized research quantities |

GHK-Cu Mechanism: Extracellular Matrix Remodeling and Collagen Synthesis

GHK-Cu functions as a high-affinity carrier of copper(II) ions, a critical cofactor for enzymes such as lysyl oxidase (LOX) and superoxide dismutase (SOD1). Preclinical research demonstrates that GHK-Cu downregulates pro-inflammatory cytokines while upregulating key structural genes involved in tissue regeneration. Researchers evaluating dermal remodeling frequently utilize GHK-Cu to measure changes in Type I and Type III collagen mRNA expression.

In vitro assays indicate that GHK-Cu accelerates wound closure rates by promoting fibroblast migration and modulating matrix metalloproteinases (MMPs) alongside their tissue inhibitors (TIMPs). This balanced enzymatic regulation prevents excessive fibrotic scarring, making GHK-Cu a foundational research compound for studying scarless tissue repair, skin remodeling, and elastin assembly. Furthermore, transcriptomic profiling shows GHK-Cu alters the expression of over 4,000 human genes, shifting cell cultures toward an anti-inflammatory and regenerative state.

SS-31 Mechanism: Cardiolipin Binding and Mitochondrial Energetics

SS-31 (D-Arg-2',6'-Dmt-Lys-Phe-NH2) features an alternating aromatic-cationic motif that allows it to penetrate cell membranes and concentrate selectively within the inner mitochondrial membrane. Its primary target is cardiolipin, a unique phospholipid essential for maintaining cristae architecture and anchoring electron transport chain complexes (Complexes I–IV) and ATP synthase into functional supercomplexes.

In models of oxidative stress, cardiolipin undergoes peroxidation, leading to cristae destabilization, electron leakage, and cytochrome c release. Preclinical studies suggest that SS-31 binds electrostatically and hydrophobically to cardiolipin, preventing peroxidative damage caused by cytochrome c peroxidase activity. By maintaining mitochondrial structural integrity, SS-31 preserves ATP generation efficiency, reduces mitochondrial reactive oxygen species (ROS) production, and inhibits apoptotic cascades in models of hypoxia, ischemia-reperfusion, and metabolic stress.

Pharmacokinetics and Half-Life Considerations in Laboratory Models

Understanding the clearance rate and stability profiles of research compounds is critical for determining dosing intervals in animal models or incubation times in cell culture assays. Both GHK-Cu and SS-31 exhibit rapid initial plasma clearance, but their tissue-specific persistence differs significantly due to their distinct targets.

GHK-Cu is susceptible to endogenous plasma carboxypeptidases, yielding an observed plasma half-life of less than one hour in rodent models unless protected in buffered vehicle solutions. However, its downstream transcriptomic effects on matrix metalloproteinases and collagen synthesis persist long after the tripeptide is cleared from circulation. Conversely, SS-31 exhibits an intravascular half-life of approximately 1 to 2 hours in rodents, but rapidly accumulates within mitochondrial membranes of metabolically active tissues (e.g., cardiac tissue, renal tubular cells, skeletal muscle), providing sustained organellar protection against oxidative insult.

Laboratory Reconstitution and Solution Handling Protocols

Both GHK-Cu and SS-31 are supplied as lyophilized powders to maximize shelf stability during transport and storage. Proper reconstitution procedures are vital to preserve structural integrity and maintain accurate molar concentrations across experimental trials.

For optimal dissolution, lyophilized vials should be reconstituted using sterile water for injection or sterile phosphate-buffered saline (PBS, pH 7.4). Researchers calculating specific stock concentrations or working dilutions should utilize our interactive reconstitution-calculator to ensure precision. Once reconstituted, stock solutions of GHK-Cu present a characteristic light blue hue due to the coordinated copper ion. Reconstituted aliquots of either compound should be stored at -20°C or -80°C to prevent enzymatic degradation or hydrolysis, avoiding repeated freeze-thaw cycles.

Selecting GHK-Cu vs SS-31 for Specific Study Designs

The selection between GHK-Cu and SS-31 depends on the primary physiological system and experimental endpoints of the research study.

Select GHK-Cu for research designs focused on: - Fibroblast proliferation and extracellular matrix deposition assays. - Transcriptomic studies evaluating gene expression in tissue repair. - Skin remodeling, elastin assembly, and collagen cross-linking assays. - Mechanisms involved in minimizing fibrotic scarring during wound healing.

Select SS-31 for research designs focused on: - Isolated mitochondrial respiration and ATP production assays. - Ischemia-reperfusion injury models in cardiac or renal tissue. - Cellular models of oxidative stress, cardiolipin oxidation, and ROS generation. - Neuroprotective and cardiotoxic resistance studies in high-energy demand cell lines.

Structural and Functional Peptide Comparisons in Tissue and Energy Pathways

To properly situate GHK-Cu and SS-31 within broader peptide research, it is helpful to compare them to other reference compounds operating in related physiological domains. For example, researchers investigating tissue repair mechanisms frequently evaluate GHK-Cu alongside BPC-157, a synthetic pentadecapeptide known for its angiogenic and cytoprotective properties in tendon and mucosal injury models.

Similarly, investigators exploring mitochondrial bioenergetics and cellular stress responses often compare SS-31 with MOTS-c, a mitochondria-derived peptide that regulates systemic metabolic homeostasis, or Epithalon, which is studied for its effects on telomerase expression and cellular senescence. Exploring these overlapping mechanisms within our research hub allows scientists to design comprehensive multi-peptide comparative protocols.

Quality Verification: HPLC, Mass Spectrometry, and Endotoxin Control

In vitro and preclinical rodent research demands strict analytical consistency to eliminate confounding variables caused by impurities, residual solvents, or bacterial contaminants. PX1 Research mandates rigorous quality assurance protocols for every production batch.

All lots of GHK-Cu and SS-31 undergo High-Performance Liquid Chromatography (HPLC) to verify chemical purity above 99%, paired with Mass Spectrometry (MS) to confirm exact molecular mass. Furthermore, every batch undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly below standard preclinical thresholds (<0.05 EU/mg). Researchers can verify independent analytical data for any lot by reviewing our published Certificate of Analysis (COA) repository prior to purchasing bulk quantities through our wholesale program.

Frequently Asked Questions

How do GHK-Cu and SS-31 differ in their primary cellular targets?

GHK-Cu targets gene expression and extracellular matrix components by delivering copper ions required for collagen synthesis and matrix remodeling. SS-31 selectively targets cardiolipin within the inner mitochondrial membrane to stabilize cristae structure and reduce reactive oxygen species (ROS).

What is the recommended solvent for reconstituting GHK-Cu and SS-31?

Both lyophilized peptides are highly water-soluble and should be reconstituted using sterile water for injection or sterile phosphate-buffered saline (PBS, pH 7.4) under aseptic laboratory conditions.

Where can researchers view lot-specific testing data for these compounds?

Lot-specific analytical documentation, including HPLC chromatograms, mass spectra, and endotoxin assay reports, is accessible directly via the PX1 Research COA portal.

What is the reported half-life of SS-31 in animal models?

In rodent plasma models, SS-31 demonstrates a half-life of approximately 1 to 2 hours, though it exhibits prolonged retention within inner mitochondrial membranes in tissue assays.

How should reconstituted GHK-Cu stock solutions be stored in the lab?

Reconstituted GHK-Cu stock solutions should be divided into single-use aliquots and stored at -20°C or -80°C to prevent hydrolytic degradation and avoid freeze-thaw degradation.

Can GHK-Cu and SS-31 be evaluated within the same experimental assay?

Yes. Researchers studying complex cellular stress responses may co-incubate both compounds in vitro to analyze concurrent extracellular matrix remodeling (GHK-Cu) and mitochondrial ROS mitigation (SS-31).

What purity levels are guaranteed for PX1 Research compounds?

PX1 Research guarantees high-purity standards (>99% purity verified via HPLC/MS) with verified low endotoxin levels (<0.05 EU/mg) across all peptide batches.

Are GHK-Cu and SS-31 approved for clinical or therapeutic use?

No. Both GHK-Cu and SS-31 are sold exclusively as research chemicals for laboratory, in vitro, and preclinical animal research use. They are not for human or veterinary administration.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.